WILLMAR, MN, February 12, 2019 — Willmar Regional Cancer Center (WRCC) has completed the installation of a new breast cancer radiation therapy technology known as “AccuBoost®”. This unique technology provides advanced targeting options for the radiation oncologist to identify the target tissue and deliver a localized, conformal radiation field while, at the same time, sparing stray radiation from healthy organs such as the heart, lungs and skin.
Under the guidance of Dr. Tod Speer, radiation oncologist, WRCC has continued to expand the advanced technologies it offers its patients. According to Dr. Speer, “We are thrilled to be able to offer AccuBoost® to our patients diagnosed with breast cancer as the technology further enhances our already formidable capabilities. I am excited to offer this image-guided therapy to our early-stage breast cancer patients who opt for Breast Conserving Therapy (BCT) as I can confidently target the cancer bed without delivering substantial dose to the surrounding healthy tissues”. WRCC is the first facility in Minnesota to offer this proven technique. The first patient treatments began in December.
AccuBoost® is a unique adaptive therapy which, unlike most breast radiation therapies, immobilizes the breast throughout imaging, targeting and treatment. This immobilization minimizes potential uncertainties in targeting. Each time a treatment is delivered, an image of the breast is taken so that the radiation oncologist can confirm the location of the target and adapt the size, shape and position of the treatment field to optimize treatment. Clinical results have been widely published showing excellent cosmesis and very low toxicity. Ultimately, the goal of BCT is to eradicate the cancer but preserve the look and feel of the woman’s breast.
For more information on AccuBoost®, visit www.AccuBoost.com.